TrialDiabetologia2018

Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial.

Joseph Proietto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.